Eribulin Advanz Pharma 0.44 mg/ml
Eribulin Advanz Pharma 0.44 mg/ml is a medicine authorised by Swissmedic under authorisation number 69924. The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 26 June 2025 and the authorisation is limited until 25 June 2030. ATC code L01XX41 places the medicine in the group Antineoplastic agents.
| Authorisation number | 69924 |
|---|---|
| Name | Eribulin Advanz Pharma 0.44 mg/ml |
| Full name | Eribulin Advanz Pharma 0.44 mg/ml, Injektionslösung |
| Authorisation holder | Advanz Pharma Specialty Medicine Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01XX41 |
| First authorisation | 26 June 2025 |
| Authorisation validity | 25 June 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Eribulin Advanz Pharma 0.44 mg/ml, Injektionslösung | A | 26 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01XX41 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Eribulin Advanz Pharma 0.44 mg/ml authorised in Switzerland?
Yes. Eribulin Advanz Pharma 0.44 mg/ml is authorised by Swissmedic under authorisation number 69924, data as of 01 September 2026. The authorisation is limited until 25 June 2030.
Which dispensing category does Eribulin Advanz Pharma 0.44 mg/ml have?
Eribulin Advanz Pharma 0.44 mg/ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Eribulin Advanz Pharma 0.44 mg/ml?
The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.